Indications

• xxx

---

Pharmacology

• Thiazolidinedione

---

Administration

• xxxx

Dose Adjustment

• Hepatic:
• Renal:

---

Adverse Effects

Cardiovascular Adverse Effects

• Peripheral Edema (see Peripheral Edema, [[Peripheral Edema]]): treatment with thiazolidinediones (eg, rosiglitazone) is associated with fluid retention in patients with HF129,132 and should be avoided in patients with NYHA class II through IV HF

Other Adverse Effects

• xxx
• xxx
• xxx

---

References

• xxxx